LEADER 03012nam  2200577Ia 450 
001 9910777641003321
005 20230828220704.0
010   $a0-309-18054-6
010   $a1-280-50667-9
010   $a9786610506675
010   $a0-309-65577-3
035   $a(CKB)1000000000465560
035   $a(EBL)3378103
035   $a(SSID)ssj0000137676
035   $a(PQKBManifestationID)11158795
035   $a(PQKBTitleCode)TC0000137676
035   $a(PQKBWorkID)10088602
035   $a(PQKB)10195975
035   $a(MiAaPQ)EBC3378103
035   $a(Au-PeEL)EBL3378103
035   $a(CaPaEBR)ebr10132071
035   $a(CaONFJC)MIL50667
035   $a(OCoLC)923275635
035   $a(EXLCZ)991000000000465560
100   $a20060809d2006      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aDeveloping a national registry of pharmacologic and biologic clinical trials$b[electronic resource] $eworkshop report /$fCommittee on Clinical Trial Registries, Board on Health Sciences Policy, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2006
215   $a1 online resource (124 p.)
300   $aDescription based upon print version of record.
311   $a0-309-10078-X 
320   $aIncludes bibliographical references (p. 47-48).
327   $a""Front Matter""; ""Independent Report Reviewers ""; ""Foreword ""; ""Preface ""; ""Contents ""; ""List of Tables ""; ""1    Summary ""; ""2  The Need for Clinical Trial Registries  ""; ""3  Current Registry Activities ""; ""4  Content of a Clinical Trial Registry ""; ""5    Implementation Issues ""; ""6  Conclusion and Next Steps ""; ""References ""; ""APPENDIXES""; ""A  Participants and Invited Experts  Between December 1, 2004, and June 27, 2005 ""; ""B  Workshop Agenda, Speakers, Panelists,  and Participants:  June 27, 2005 ""
327   $a""C  Section 113 of the Food and Drug  Administration Modernization Act of 1997  and  Guidance for Industry: Information Programs  on Clinical Trials for Serious or Life- Threatening Diseases and Conditions. U.S. Department of Health and Human  Services.""""D  Published Journal Editorials ""; ""E  Joint Position on the  Disclosure of Clinical Trial Information via  Clinical Trial Registries and Databases""; ""F  Illustrative Data Fields for the  Results Summary (based on ICH E3 template) ""; ""G Biographical Sketches of  Committee Members ""
606   $aClinical trials$zUnited States
606   $aClinical medicine$xResearch
615  0$aClinical trials
615  0$aClinical medicine$xResearch.
676   $a615.5072
712 02$aInstitute of Medicine (U.S.).$bCommittee on Clinical Trial Registries.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910777641003321
996   $aDeveloping a national registry of pharmacologic and biologic clinical trials$93830700
997   $aUNINA